"Hyperprolactinemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
| Descriptor ID |
D006966
|
| MeSH Number(s) |
C10.228.140.617.738.250.450 C19.700.355.600
|
| Concept/Terms |
Hyperprolactinemia- Hyperprolactinemia
- Hyperprolactinemias
- Prolactin, Inappropriate Secretion
- Inappropriate Secretion Prolactin
- Secretion Prolactin, Inappropriate
- Inappropriate Prolactin Secretion Syndrome
- Prolactin Hypersecretion Syndrome
- Hypersecretion Syndrome, Prolactin
- Syndrome, Prolactin Hypersecretion
- Hyperprolactinaemia
- Inappropriate Prolactin Secretion
- Prolactin Secretion, Inappropriate
- Secretion, Inappropriate Prolactin
|
Below are MeSH descriptors whose meaning is more general than "Hyperprolactinemia".
Below are MeSH descriptors whose meaning is more specific than "Hyperprolactinemia".
This graph shows the total number of publications written about "Hyperprolactinemia" by people in this website by year, and whether "Hyperprolactinemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2010 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyperprolactinemia" by people in Profiles.
-
Endoscopic Endonasal Transsphenoidal Surgery for Patients with Prolactinomas: Indications and Outcomes. World Neurosurg. 2022 12; 168:e626-e635.
-
Levosulpiride-induced Hyperprolactinemia. J Coll Physicians Surg Pak. 2020 Apr; 30(4):457.
-
Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions. Breast Cancer Res. 2018 05 19; 20(1):42.
-
Calcium and Vitamin D Supplementation in Boys with Risperidone-Induced Hyperprolactinemia: A Randomized, Placebo-Controlled Pilot Study. J Child Adolesc Psychopharmacol. 2018 03; 28(2):145-150.
-
Late endocrine effects of childhood cancer. Nat Rev Endocrinol. 2016 06; 12(6):319-36.
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: CLINICAL RELEVANCE OF MACROPROLACTIN IN THE ABSENCE OR PRESENCE OF TRUE HYPERPROLACTINEMIA. Endocr Pract. 2015 Dec; 21(12):1427-35.
-
Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study. Psychoneuroendocrinology. 2015 Aug; 58:130-40.
-
A predictive algorithm for evaluating elevated serum prolactin in patients with a sellar mass. J Clin Neurosci. 2015 Jan; 22(1):155-60.
-
AACE/ACE Disease State Clinical Review: Dopamine Agonists for Hyperprolactinemia and the Risk of Cardiac Valve Disease. Endocr Pract. 2014 Jun; 20(6):608-16.
-
Increased prolactin concentrations in a patient with bipolar disorder. Clin Chem. 2013 Mar; 59(3):473-5.